Literature DB >> 23147144

A single nucleotide polymorphism, rs129679860, in the IL28B locus is associated with the viral kinetics and a sustained virological response in a chronic, monoinfected hepatitis C virus genotype-1 Brazilian population treated with pegylated interferon-ribavirin.

Juliene Antonio Ramos1, Ana Lúcia de Araújo Ramos, Luisa Hoffmann, Renata de Mello Perez, Henrique Sérgio Moraes Coelho, Turán Péter Urményi, Rosane Silva, Edson Rondinelli, Cristiane Alves Villela-Nogueira.   

Abstract

Single nucleotide polymorphisms (SNPs) in the interleukin (IL)28B locus have been associated with a sustained virological response (SVR) in interferon-ribavirin (IFN-RBV)-treated chronic hepatitis C virus (HCV)-infected patients in European and African populations. In this study, the genotype frequency of two IL28B SNPs (rs129679860 and rs8099917) in a cohort of chronic HCV-monoinfected patients in Brazil was evaluated and the SNP sufficient to predict the treatment response outcome was determined. A total of 66 naïve genotype-1 chronic HCV-infected patients were genotyped and the associated viral kinetics and SVR were assessed. The overall SVR was 38%. Both the viral kinetics and SVR were associated with rs129679860 genotypes (CC = 62% vs. CT = 33% vs. TT = 18%, p = 0.016). However, rs8099917 genotypes were only associated with SVR (TT = 53% vs. TG = 33% vs. GG = 18%; p = 0.032). In this population, the analysis of a single SNP, rs12979860, successfully predicts SVR in the IFN-RBV treatment of HCV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147144     DOI: 10.1590/s0074-02762012000700008

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?

Authors:  Raquel Francine Liermann Garcia; Simone Moreira; Ana Lucia de Araújo Ramos; Leslie Ecker Ferreira; Angelo Alves de Mattos; Cristiane Valle Tovo; Lysandro Alsina Nader; Juliene Antonio Ramos; Edson Rondinelli; Arnaldo de Jesus Dominici; Christian Evangelista Garcia; Mauro de Souza Leite Pinho; Carlos Eduardo Brandão-Mello; Cristiane Alves Villela-Nogueira; Paulo Henrique Condeixa de França
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 2.  Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.

Authors:  E Cariani; L Roli; G Missale; E Villa; C Ferrari; T Trenti
Journal:  Pharmacogenomics J       Date:  2015-04-28       Impact factor: 3.550

3.  IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients.

Authors:  Bruna C Bertol; Simone Moreira; Raquel F L Garcia; Leslie E Ferreira; Guilherme Debortoli; Mauro de Souza Leite Pinho; Marcia Amendola-Pires; Alessandra M de Almeida Maciel; Carlos E Brandço-Mello; Paulo H C de França
Journal:  Front Microbiol       Date:  2015-03-04       Impact factor: 5.640

4.  Distribution of IL-28B genotypes in patients with hepatitis C and healthy individuals in Jahrom city.

Authors:  Seyed Dawood Mousavi Nasab; Rasoul Baharlou; Ahmad Piroozmand; Hadi Toghyani; Enayatollah Shadmand; Hadi Fazel; Kaveh Sadeghi; Seyed Mohammad Ali Hashemi; Mohammad Reza Shokouh; Abulfazl Gheshlaghi; Nayeb Ali Ahmadi; Abbas Ahmadi Vasmehjani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

5.  IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.

Authors:  Natalia Echeverría; Daniela Chiodi; Pablo López; Adriana Sanchez Ciceron; Jenniffer Angulo; Marcelo López-Lastra; Paola Silvera; Adrian Canavesi; Carla Bianchi; Valentina Colistro; Juan Cristina; Nelia Hernandez; Pilar Moreno
Journal:  Virol J       Date:  2018-03-02       Impact factor: 4.099

6.  Interferon-lambda 3 and 4 Polymorphisms Increase Sustained Virological Responses and Regulate Innate Immunity in Antiviral Therapy With Pegylated Interferon-Alpha.

Authors:  Andréa Marques Vieira da Silva; Lucia Elena Alvarado-Arnez; Tamiris Azamor; Leonardo Ribeiro Batista-Silva; Thyago Leal-Calvo; Ohanna Cavalcanti de Lima Bezerra; Marcelo Ribeiro-Alves; Fernanda de Souza Gomes Kehdy; Patrícia Cristina da Costa Neves; Camilla Bayma; Jane da Silva; Alessandro Fonseca de Souza; Marcelo Muller; Elisabete Ferreira de Andrade; Ana Carolina Magalhães Andrade; Eliane Matos Dos Santos; Janaína Reis Xavier; Maria De Lourdes De Sousa Maia; Rolando Páez Meireles; Hugo Nodarse Cuni; Guilherme Becker Sander; Paulo Dornelles Picon; Denise C S Matos; Milton Ozório Moraes
Journal:  Front Cell Infect Microbiol       Date:  2021-07-07       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.